Generic Name and Formulations:
Ciprofloxacin (as HCl) 0.3%; oph. soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for CILOXAN:
Susceptible infections of conjunctiva and cornea.
Adults and Children:
Conjunctivitis: 1–2 drops in conjunctival sac(s) every 2 hours while awake for 2 days, then 1–2 drops every 4 hours while awake for next 5 days. Corneal ulcers: 2 drops every 15 minutes for 1st 6 hours, then 2 drops every 30 minutes for rest of 1st day; 2nd day: 2 drops every 1 hour; 3rd–14th days: 2 drops every 4 hours. May treat for 14 days or until corneal re-epithelialization occurs.
CNS or convulsive disorders. Discontinue if rash occurs. Pregnancy (Cat.C). Nursing mothers.
May increase theophylline levels. May potentiate oral anticoagulants. May increase renal toxicity with cyclosporine.
Soln: Burning, crystalline precipitates, lid margin crusting, scales, foreign body sensation, pruritus, conjunctival hyperemia, bad taste. Oint: ocular discomfort, blurred vision; may delay corneal healing. Both: superinfection.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics